Literature DB >> 29250766

Expression of miRNA-146a, miRNA-155, IL-2, and TNF-α in inflammatory response to Helicobacter pylori infection associated with cancer progression.

Luanna Munhoz Zabaglia1, Mayara Luciana Sallas1, Mônica Pezenatto Dos Santos1, Wilson Aparecido Orcini1, Rita Luiza Peruquetti1, Dulce Helena Constantino1, Elizabeth Chen2, Marilia De Arruda Cardoso Smith2, Spencer-Luiz Marques Payão1, Lucas Trevizani Rasmussen1.   

Abstract

miRNAs appear to play an important role in controlling the expression of several genes, and they are a potential biomarker and prognostic tool in gastric diseases. We analyzed 53 controls, 86 patients with gastritis, and 19 patients with gastric cancer. Real-time-PCR was used to determine the expression levels of miRNA-146a, miRNA-155, IL-2, and TNF-α. The subsequent analysis of the target genes was performed using the bioinformatics approach. There was no difference in IL-2 expression between the groups. However, there was a significant increase in TNF-α expression in the gastritis group relative to the control and a significant decrease in the gastric cancer group relative to the control. There was also a statistically significant increase in miRNA-146a and miRNA-155 expression in the gastritis group relative to the control, but not in the gastric cancer group. Similar results were found when the presence of H. pylori was considered. The data revealed an increase in miRNA-146a and miRNA-155 expression but not enough to control the expression of TNF-α. The presence of H. pylori was found to affect increases in TNF-α and microRNA expression, and miRNA-146a and miRNA-155 alone were not able to eliminate bacteria or restore tissue homeostasis.
© 2017 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Gastric disease; Helicobacter pylori, Interleukin 2; TNF-α; miRNA-146a; miRNA-155

Mesh:

Substances:

Year:  2017        PMID: 29250766     DOI: 10.1111/ahg.12234

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  6 in total

1.  Comprehensive analysis of differentially expressed serum microRNAs in humans responding to Brucella infection.

Authors:  Cuiping Zhang; Quan Fu; Meng Ding; Tingting Chen; Xiaolan Lu; Yujie Zhong; Yuying Bian; Fengmin Zhang; Chen-Yu Zhang; Chunni Zhang; Cheng Wang
Journal:  Ann Transl Med       Date:  2019-07

2.  MiR-32-5p aggravates intestinal epithelial cell injury in pediatric enteritis induced by Helicobacter pylori.

Authors:  Jing Feng; Jian Guo; Jun-Ping Wang; Bao-Feng Chai
Journal:  World J Gastroenterol       Date:  2019-11-07       Impact factor: 5.742

Review 3.  Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy.

Authors:  Xiaomin Liu; Yang Shao; Jinbao Zhou; Guangren Qian; Zhongliang Ma
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-18       Impact factor: 8.886

4.  In Peripheral Blood Mononuclear Cells Helicobacter pylori Induces the Secretion of Soluble and Exosomal Cytokines Related to Carcinogenesis.

Authors:  Josefina Atrisco-Morales; Mónica Ramírez; Carlos Alberto Castañón-Sánchez; Adolfo Román-Román; Ilce Valeria Román-Fernández; Dinorah Nashely Martínez-Carrillo; Samuel García-Arellano; José Francisco Muñoz-Valle; Hugo Alberto Rodríguez-Ruiz; Gloria Fernández-Tilapa
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

5.  Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway.

Authors:  Haiqun Chen; Gang Dai; Yiting Cai; Qinhao Gong; Wei Wu; Min Gao; Zhewei Fei
Journal:  Cancer Cell Int       Date:  2018-07-09       Impact factor: 5.722

6.  Toll-like receptor 9 polymorphisms and Helicobacter pylori influence gene expression and risk of gastric carcinogenesis in the Brazilian population.

Authors:  Manoela Dias Susi; de Matos Lourenço Caroline; Lucas Trevizani Rasmussen; Spencer Luis Marques Payão; Ana Flávia Teixeira Rossi; Ana Elizabete Silva; Juliana Garcia de Oliveira-Cucolo
Journal:  World J Gastrointest Oncol       Date:  2019-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.